HomeNewsTrendsHealthDelhi: Omicron found in 97% samples taken from deceased patients from January to March

Delhi: Omicron found in 97% samples taken from deceased patients from January to March

Genome sequencing of 578 samples collected from the deceased showed 560 of them had the Omicron variant.

April 20, 2022 / 16:39 IST
Image Source: Reuters

Ninety-seven percent of the samples taken from those who died of COVID in Delhi from January to March had the Omicron variant of coronavirus, according to government data.

Genome sequencing of 578 samples collected from the deceased showed 560 of them had the Omicron variant.

The remaining 18 (three percent) had other variants of COVID-19, including Delta, which fuelled the ferocious second wave of infections in April and May last year, and sub lineages.

Overall, the Omicron variant was found in all the 504 samples analysed at genome sequencing laboratories in the capital in March.

The third wave of infections driven by the Omicron variant saw lesser hospitalisations and severe cases in the national capital and government data showed the virus isn’t the primary reason in most fatalities.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

A maximum of 2,784 (17.96 percent) of the 15,505 COVID-19 beds in hospitals were occupied on January 17.

During the second wave, 20,117 (92 per cent) of the 21,839 beds were occupied on May 6.

Delhi is once again seeing a spurt in the number of infections, with experts attributing it to a large number of people not following COVID-appropriate behaviour, including the mask mandate.

In view of the spike in cases, the Delhi government on Wednesday made wearing of masks mandatory in public places and imposed a fine of Rs 500 on violators.

Officials said the Delhi Disaster Management Authority, in its meeting, also decided not to shut schools, but chose to come up with a separate Standard Operating Procedure in consultation with experts.

Delhi has also started genome sequencing of samples of all COVID infected people in the capital to ascertain if a new variant, such as the XE variant, has spread in the city.

PTI
first published: Apr 20, 2022 04:39 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347